Assessment of the antimicrobial effectiveness of a new silver alginate wound dressing: a RCT
- PMID: 20081570
- DOI: 10.12968/jowc.2010.19.1.46095
Assessment of the antimicrobial effectiveness of a new silver alginate wound dressing: a RCT
Erratum in
- J Wound Care. 2010 Mar;19(3):109
Abstract
Objective: To compare the efficacy and tolerability of a new ionic silver alginate matrix (Askina Calgitrol Ag) with that of a standard silver-free alginate dressing (Algosteril).
Method: Patients with locally infected chronic wounds (pressure ulcers, venous or mixed aetiology leg ulcers, diabetic foot ulcers) or acute wounds were eligible for this prospective, open-label, controlled and randomised trial. Patients were randomised to receive one of the two dressings for a two-week period. Criteria of efficacy were based on the evolution, from day 1 to day 15, of local signs of infection using a clinical score ranging from 0 to 18, and the evolution of the bacteriological status for each wound. The latter was determined by (blind) bacteriological examinations of results obtained from two biopsies performed at days 1 and 15. A three-point scale (deterioration, unchanged, improvement) was also used. Acceptability, usefulness and tolerance were also assessed.
Results: Forty-two patients (20 women and 22 men, 68.9 +/- 18.8 and 66.5 +/- 15.7 years old respectively) were randomly assigned to receive either Askina Calgitrol Ag (n=20) or Algosteril (n=22). Most had chronic wounds such as pressure ulcers (57%) or venous or mixed aetiology leg ulcers and diabetic foot ulcers (29%); few had acute wounds (14%). Clinical scores of infection were comparable in both groups at inclusion, 8.9 +/- 2.4 and 8.6 +/- 3.2 in the Askina Calgitrol Ag group and the Algosteril group respectively (not significant), but decreased significantly in both groups at day 15, 3.8 +/- 2.9 in the Askina Calgitrol Ag group (p=0.001) and 3.8 +/- 3.4 in the Algosteril group (p=0.007). There was no significant difference between the two groups at day 15. Although there was also no significant difference in bacteriological status between the treatment groups, a trend in favour of Askina Calgitrol Ag was found for the relative risk of improvement, especially in patients who were not treated with antibiotics either at the beginning of the study or during it. No differences between groups were observed regarding local tolerance, acceptability and usefulness of the dressings.
Conclusion: The regression of local signs of infection, local tolerance, acceptability and usefulness were similar for the two dressings. However, Askina Calgitrol Ag improved the bacteriological status of the wounds. Further trials are required to show that it has a positive impact on the healing process.
Similar articles
-
Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection.J Wound Care. 2005 Oct;14(9):411-9. doi: 10.12968/jowc.2005.14.9.26835. J Wound Care. 2005. PMID: 16240620 Clinical Trial.
-
Clinical effectiveness of alginate silver dressing in outpatient management of partial-thickness burns.Int Wound J. 2010 Dec;7(6):467-71. doi: 10.1111/j.1742-481X.2010.00718.x. Epub 2010 Sep 21. Int Wound J. 2010. PMID: 20860635 Free PMC article. Clinical Trial.
-
Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study.J Wound Care. 2015 Mar;24(3):121-2; 124-7. doi: 10.12968/jowc.2015.24.3.121. J Wound Care. 2015. PMID: 25764956 Clinical Trial.
-
Silver dressings--do they work?Drug Ther Bull. 2010 Apr;48(4):38-42. doi: 10.1136/dtb.2010.02.0014. Drug Ther Bull. 2010. PMID: 20392779 Review.
-
Contreet Foam and Contreet Hydrocolloid: an insight into two new silver-containing dressings.J Wound Care. 2003 Jun;12(6):205-10. doi: 10.12968/jowc.2003.12.6.26507. J Wound Care. 2003. PMID: 12838596 Review.
Cited by
-
Alginate dressings for treating pressure ulcers.Cochrane Database Syst Rev. 2015 May 21;2015(5):CD011277. doi: 10.1002/14651858.CD011277.pub2. Cochrane Database Syst Rev. 2015. PMID: 25994366 Free PMC article.
-
Advanced Wound Care Strategies in Patients with NSTIs.J Clin Med. 2025 May 17;14(10):3514. doi: 10.3390/jcm14103514. J Clin Med. 2025. PMID: 40429509 Free PMC article. Review.
-
Alginate and alginate composites for biomedical applications.Asian J Pharm Sci. 2021 May;16(3):280-306. doi: 10.1016/j.ajps.2020.10.001. Epub 2020 Nov 5. Asian J Pharm Sci. 2021. PMID: 34276819 Free PMC article. Review.
-
Silver and Alginates: Role in Wound Healing and Biofilm Control.Adv Wound Care (New Rochelle). 2015 Jul 1;4(7):407-414. doi: 10.1089/wound.2014.0541. Adv Wound Care (New Rochelle). 2015. PMID: 26155383 Free PMC article. Review.
-
Antibiotics and antiseptics for pressure ulcers.Cochrane Database Syst Rev. 2016 Apr 4;4(4):CD011586. doi: 10.1002/14651858.CD011586.pub2. Cochrane Database Syst Rev. 2016. PMID: 27040598 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical